The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Size Growth Is Projected For The Rheumatic Heart Disease Market During The Forecast Period 2026–2030?
The rheumatic heart disease market size has seen substantial growth over recent years. It is anticipated to expand from $2.71 billion in 2025 to $2.88 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.1%. The historical development of this market can be linked to a high incidence of untreated streptococcal infections, restricted access to initial healthcare in developing regions, the enduring impact of rheumatic fever, reliance on clinical diagnostic approaches, and the limited provision of advanced cardiac treatment.
The rheumatic heart disease market size is projected to witness substantial growth in the coming years, reaching $3.6 billion in 2030 with a compound annual growth rate (CAGR) of 5.8%. This expansion during the forecast period can be ascribed to escalating investments in public health screening programs, the rising adoption of digital cardiac diagnostics, growing awareness about the advantages of early intervention, the expansion of cardiac surgical infrastructure, and an increased emphasis on disease prevention strategies. Key trends anticipated during this period include a broader adoption of early diagnostic screening programs, an increasing utilization of echocardiography and imaging tools, a developing focus on preventive antibiotic therapies, the expansion of valve repair and replacement procedures, and enhanced monitoring for pediatric and adolescent patients.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=23502&type=smp
Which Major Factors Are Driving The Expansion Of The Rheumatic Heart Disease Market?
The rheumatic heart disease market is anticipated to expand, driven by the increasing prevalence of strep throat. Strep throat is a bacterial infection caused by Streptococcus pyogenes (Group A Streptococcus), which results in inflammation and pain in the throat, frequently accompanied by fever, swollen lymph nodes, and difficulty swallowing. Growing antibiotic resistance is making streptococcal infections more challenging to treat effectively, leading to prolonged illness and increased transmission rates in communities. Rheumatic heart disease develops as a long-term complication when strep throat infections are left untreated or recur, highlighting the critical need for early diagnosis and treatment of streptococcal infections to prevent severe heart damage. For instance, in April 2023, according to the Centers for Disease Control and Prevention, a US-based government department, strep throat is responsible for an estimated 5.2 million outpatient visits annually among individuals younger than 65 years old. These visits lead to 2.8 million antibiotic prescriptions each year. Therefore, the increasing prevalence of strep throat is propelling the growth of the rheumatic heart disease market.
What Market Segments Are Evaluated Within The Rheumatic Heart Disease Market?
The rheumatic heart disease market covered in this report is segmented –
1) By Type: Valve, Myocarditis, Pericarditis
2) By Age Group: Pediatric, Adolescent, Adult, Geriatric
3) By Application: Hospital, Diagnostic Centre, Research Centre
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Direct Sales
Subsegments:
1) By Valve: Mitral Valve Disease, Aortic Valve Disease, Tricuspid Valve Disease, Pulmonary Valve Disease
2) By Myocarditis: Acute Myocarditis, Chronic Myocarditis, Fulminant Myocarditis
3) By Pericarditis: Acute Pericarditis, Chronic Pericarditis, Constrictive Pericarditis, Effusive Pericarditis
Which Trends Are Impacting The Growth Of The Rheumatic Heart Disease Market?
Leading organizations active in the rheumatic heart disease market are increasingly pursuing strategic collaborations to advance the creation of novel treatments and diagnostic solutions. These strategic alliances in the realm of rheumatic heart disease (RHD) management bring together diverse resources and specialized knowledge, aiming to propel research and development, improve diagnostic and therapeutic breakthroughs, broaden market reach, and expedite commercialization processes. As an illustration, in July 2023, the World Heart Federation (WHF), a non-governmental organization headquartered in Switzerland, entered into a partnership with the Philips Foundation, a nonprofit entity from the Netherlands, with the goal of enhancing awareness, providing medical education, and facilitating the prompt detection of rheumatic heart disease (RHD) across the Asia-Pacific (APAC) region. This initiative, which commenced in the Philippines, endeavors to boost healthcare accessibility for more than half a million at-risk Filipino children by furnishing medical centers with skilled personnel and sophisticated diagnostic equipment. The joint effort highlights a collective dedication to reinforcing the healthcare framework and ensuring prompt treatment for individuals with RHD.
Who Are The Top Market Participants Influencing The Rheumatic Heart Disease Market?
Major companies operating in the rheumatic heart disease market are Pfizer Inc., Merck And Co Inc., Bayer AG, Sanofi SA, AstraZeneca plc, Novartis AG, Abbott Laboratories, GlaxoSmithKline plc, Medtronic plc, Siemens Healthineers AG, Becton Dickinson And Company, GE HealthCare Technologies Inc., Boston Scientific Corporation, Terumo Corporation, Apollo Hospitals Enterprise Limited, Fortis Healthcare Limited, Medanta, Johnson And Johnson Services Inc., Roche Holding AG, Bristol Myers Squibb Company, Takeda Pharmaceutical Company Limited, Daiichi Sankyo Company, Boehringer Ingelheim International GmbH, Edwards Lifesciences Corporation
Read the full rheumatic heart disease market report here:
https://www.thebusinessresearchcompany.com/report/rheumatic-heart-disease-global-market-report
Which Region Currently Holds The Largest Share Of The Rheumatic Heart Disease Market?
North America was the largest region in the rheumatic heart disease market in 2025. The regions covered in the rheumatic heart disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Rheumatic Heart Disease Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=23502&type=smp
Browse Through More Reports Similar to the Global Rheumatic Heart Disease Market 2026, By The Business Research Company
Soft Tissue Sarcoma Global Market Report
https://www.thebusinessresearchcompany.com/report/soft-tissue-sarcoma-global-market-report
Medulloblastoma Drug Global Market Report
https://www.thebusinessresearchcompany.com/report/medulloblastoma-drug-global-market-report
Emphysema Global Market Report
https://www.thebusinessresearchcompany.com/report/emphysema-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model